Clinical Kidney Journal
Impact of dapagliflozin on bone mineral metabolism in non-diabetic patients with chronic kidney disease: a randomized, double-blind, placebo-controlled study
Randomized trial in 100 peopleDapagliflozin
848 papers29 new in 30 days